INDmoney
Travere Therapeutics Inc Stock Performance
as on January 28, 2026 at 9:39 pm IST
Day's Low
Day's High
$29.21$30.40
2.21%
Downside
1.77%
Upside
52 Week's Low
52 Week's High
$12.91$42.1356.78%
Downside
41.04%
Upside
Travere Therapeutics Inc share price movements today
- Previous Close
- $30.03
- Open
- $29.90
- Volume
- 239.0K
- Day's Low - High
- $29.21 - $30.40
- 52 Week Low - High
- $12.91 - $42.13
Travere Therapeutics Inc Historical Returns
- 1 Month Return
- -24.24 %
- 3 Month Return
- + 0.74 %
- 1 Year Return
- + 42.32 %
- 3 Year Return
- + 37.25 %
- 5 Year Return
- + 16.44 %
Travere Therapeutics Inc Stock Fundamentals & Key Indicators
Check Travere Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.7B
EPS (TTM)
0.9114
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-35.0M
Revenue (TTM)
435.8M
Profit Margin
-20.32%
Return On Equity TTM
-410.78%
Travere Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Travere Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.7B | 16.44% | NA | -20.32% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
Stock Returns calculator for Travere Therapeutics Inc Stock including INR - Dollar returns
The Travere Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Travere Therapeutics Inc investment value today
Current value as on today
₹1,47,538
Returns
₹47,538
(+47.54%)
Returns from Travere Therapeutics Inc Stock
₹41,564 (+41.56%)
Dollar Returns*
₹5,974 (+5.97%)
Analyst Recommendation on Travere Therapeutics Inc Stock
Based on 22 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 22 analysts, 72.73% of analysts recommend a 'BUY' rating for Travere Therapeutics Inc. Average target price of $42.07
Travere Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Travere Therapeutics Inc.
What analysts predicted
29%UPSIDE
Target Price
$42.07
Current Price
$29.87
Analyzed by
22 Analysts
Target
$42.07
Travere Therapeutics Inc target price $42.07, a slight upside of 29% compared to current price of $29.87. According to 22 analysts rating.
Travere Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Travere Therapeutics Inc Stock has increased by 96% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:96% versus previous 30 day period
Travere Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Travere Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Travere Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Travere Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Travere Therapeutics Inc News & Key Events
Today's Timeline - 13 January
Tue, 06:03 PM
-Travere Therapeutics stock tumbled 28% after FDA requested additional information on a kidney disorder drug's clinical benefits.
Tue, 06:34 PM
-Shares of Travere fell 28.2% in pre-market after issuing a corporate update and 2026 outlook.
Tue, 11:07 PM
-Biopharma stock tumbled 32% following FDA's request for more information on kidney disorder drug.
Insights on Travere Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 7 quarters, 41.37M → 164.85M (in $), with an average increase of 20.2% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, -60.26M → 25.70M (in $), with an average increase of 139.7% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, TVTX has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 6.0%
NEGATIVE IMPACTPrice Dip
In the last 1 month, TVTX stock has moved down by -24.2%
About Travere Therapeutics Inc
| Organisation | Travere Therapeutics Inc |
| Headquarters | 3611 Valley Centre Drive, San Diego, CA, United States, 92130 |
| Industry | Health Technology |
| CEO | Dr. Eric M. Dube Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Travere Therapeutics Inc
Name | Title |
|---|---|
Dr. William E. Rote Ph.D. | Chief Research Officer |
Mr. Peter Heerma | Chief Commercial Officer |
Ms. Nivi Nehra | Vice President of Corporate Communications & Investor Relations |
Ms. Sandra Calvin | SVP, Corporate Controller & Chief Accounting Officer |
Ms. Elizabeth E. Reed J.D. | Chief Legal Officer, General Counsel & Secretary |
Ms. Angela Giannantonio | Chief People Officer |
Mr. Casey Logan | Chief Business Officer |
Dr. Eric M. Dube Ph.D. | President, CEO & Director |
Mr. Christopher Cline C.F.A. | Chief Financial Officer |
Dr. Jula Inrig M.D. | Chief Medical Officer |
FAQs
What is Travere Therapeutics Inc share price today?
Travere Therapeutics Inc share price today is $29.87 as on . Travere Therapeutics Inc share today touched a day high of $30.4 and a low of $29.21.
What is the 52 week high and 52 week low for Travere Therapeutics Inc share?
Travere Therapeutics Inc share touched a 52 week high of $42.13 on and a 52 week low of $12.91 on . Travere Therapeutics Inc stock price today i.e. is trending at $29.87,which is 29.10% down from its 52 week high and 131.37% up from its 52 week low.
What is Travere Therapeutics Inc's market capitalisation today?
Travere Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Travere Therapeutics Inc Stock (TVTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Travere Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Travere Therapeutics Inc Shares that will get you 0.0502 shares as per Travere Therapeutics Inc share price of $29.87 per share as on January 28, 2026 at 9:39 pm IST.
What is the minimum amount required to buy Travere Therapeutics Inc Stock (TVTX) from India?
Indian investors can start investing in Travere Therapeutics Inc (TVTX) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Travere Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Travere Therapeutics Inc share’s latest price of $29.87 as on January 28, 2026 at 9:39 pm IST, you will get 0.3348 shares of Travere Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Travere Therapeutics Inc has given to Indian investors in the last 5 years?
Travere Therapeutics Inc stock has given 16.44% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?